CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹25,774 Cr | ₹22,753 Cr | ₹21,763 Cr | ₹19,160 Cr | ₹17,132 Cr |
What is the latest Revenue of CIPLA ?
Year | Revenue |
---|---|
Mar2025 | ₹25,774 Cr |
Mar2024 | ₹22,753 Cr |
Mar2023 | ₹21,763 Cr |
Mar2022 | ₹19,160 Cr |
Mar2021 | ₹17,132 Cr |
How is Revenue of CIPLA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹25,774 Cr | 13.28 | |
Mar2024 | ₹22,753 Cr | 4.55 | |
Mar2023 | ₹21,763 Cr | 13.59 | |
Mar2022 | ₹19,160 Cr | 11.84 | |
Mar2021 | ₹17,132 Cr | - |
Compare Revenue of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,021.7 Cr | -0.3% | 0.9% | -3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,686.0 Cr | 0.8% | -1.3% | 10.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,075.0 Cr | 1.5% | 2.3% | 47.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,971.0 Cr | -0.1% | 7.2% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,121.0 Cr | -2.7% | -0.3% | 9.9% | Stock Analytics | |
MANKIND PHARMA | ₹94,907.0 Cr | -2.3% | -5.5% | 3.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.3% |
0.9% |
-3.8% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses